申请人:HOWARD FLOREY INSTITUTE OF
EXPERIMENTAL PHYSIOLOGY AND MEDICINE
公开号:EP0972779A2
公开(公告)日:2000-01-19
Oligonucleotide-polyamide conjugates of the formula X-L-Y, where X is a polyamide, Y is an oligonucleotide, and L is a linker which forms a covalent bond with the amino-terminus of the polyamide X and the 3' phosphate group of the oligonucleotide Y. Conjugates may be synthesized by assembling a polyamide on a solid support matrix, adding a suitable linker molecule, followed by synthesis of the oligonucleotide. Methods for detecting specific polynucleotides with oligonucleotide-polyamide conjugates are also described.
式 X-L-Y 的寡核苷酸-聚酰胺共轭物,其中 X 是聚酰胺,Y 是寡核苷酸,L 是连接体,它与聚酰胺 X 的氨基末端和寡核苷酸 Y 的 3'磷酸基团形成共价键。可通过在固体支持基质上组装聚酰胺,加入合适的连接分子,然后合成寡核苷酸来合成共轭物。还介绍了用寡核苷酸-聚酰胺共轭物检测特定多核苷酸的方法。
MOLECULAR MODULE
申请人:The University of Tokyo
公开号:EP2098538A1
公开(公告)日:2009-09-09
The present invention aims at providing a general-purpose experimental tool which specifically binds to a macromolecular substance that will be a receptor for a specific ligand such as drug, and is applicable throughout various processes to explore the nature of the macromolecular substance. In order to achieve this object, a molecular module has been developed which binds to a target compound and is used for purifying or labeling the target compound, wherein the molecular module has a rod-like spacer substance, an interacting substance that interacts with the target compound, a tag and a labeling substance, the interacting substance being positioned at one end of the rod-like spacer substance, and the tag and the labeling substance being positioned at the other end of the rod-like spacer substance.
Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation
申请人:Baker F. Brenda
公开号:US20050037370A1
公开(公告)日:2005-02-17
Oligomer compositions comprising first and second oligomers are provided wherein at least a portion of the first oligomer is capable of hybridizing with at least a portion of the second oligomer, at least a portion of the first oligomer is complementary to and capble of hybridizing to a selected target nucleic acid, and at least one of the first or second oligomers has a modified base for binding to an adenine or guanine base in the opposite strand. Oligonucleotide/protein compositions are also provided comprising an oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex (RISC), wherein the oligomer has a modified base for binding to an adenine or guanine base in the opposite strand.